Free Trial

Fiera Capital Corp Raises Position in Doximity, Inc. (NASDAQ:DOCS)

Doximity logo with Medical background

Fiera Capital Corp raised its holdings in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 1.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 309,630 shares of the company's stock after buying an additional 4,915 shares during the quarter. Fiera Capital Corp owned about 0.17% of Doximity worth $17,968,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. VSM Wealth Advisory LLC purchased a new position in shares of Doximity in the 1st quarter worth about $29,000. Allworth Financial LP boosted its holdings in shares of Doximity by 104.0% in the 1st quarter. Allworth Financial LP now owns 563 shares of the company's stock worth $32,000 after purchasing an additional 287 shares in the last quarter. Spire Wealth Management boosted its holdings in shares of Doximity by 73.2% in the 1st quarter. Spire Wealth Management now owns 615 shares of the company's stock worth $36,000 after purchasing an additional 260 shares in the last quarter. Kapitalo Investimentos Ltda bought a new stake in shares of Doximity in the 4th quarter valued at about $50,000. Finally, Huntington National Bank lifted its stake in shares of Doximity by 1,440.8% in the 4th quarter. Huntington National Bank now owns 1,094 shares of the company's stock valued at $58,000 after acquiring an additional 1,023 shares during the last quarter. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Doximity

In other Doximity news, Director Regina M. Benjamin sold 10,000 shares of the firm's stock in a transaction that occurred on Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total transaction of $600,000.00. Following the completion of the transaction, the director owned 16,618 shares in the company, valued at $997,080. This trade represents a 37.57% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Kira Scherer Wampler sold 2,000 shares of the firm's stock in a transaction that occurred on Friday, August 1st. The shares were sold at an average price of $57.09, for a total value of $114,180.00. Following the transaction, the director owned 16,618 shares of the company's stock, valued at $948,721.62. This represents a 10.74% decrease in their position. The disclosure for this sale can be found here. Insiders sold 31,000 shares of company stock worth $1,825,940 in the last quarter. 37.40% of the stock is owned by corporate insiders.

Doximity Stock Performance

Shares of Doximity stock traded down $1.45 during trading hours on Friday, hitting $57.30. The company's stock had a trading volume of 1,489,193 shares, compared to its average volume of 2,352,441. The business has a 50 day moving average price of $58.39 and a two-hundred day moving average price of $59.79. Doximity, Inc. has a 12-month low of $25.00 and a 12-month high of $85.21. The company has a market cap of $10.76 billion, a PE ratio of 57.30, a PEG ratio of 4.10 and a beta of 1.37.

Doximity (NASDAQ:DOCS - Get Free Report) last announced its quarterly earnings data on Thursday, May 15th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. During the same period in the prior year, the business earned $0.25 EPS. The firm's revenue for the quarter was up 17.1% compared to the same quarter last year. As a group, research analysts anticipate that Doximity, Inc. will post 0.99 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts recently issued reports on DOCS shares. Bank of America boosted their price target on shares of Doximity from $55.00 to $62.00 and gave the company a "neutral" rating in a research report on Wednesday, June 25th. Morgan Stanley lowered their price objective on Doximity from $71.00 to $60.00 and set an "equal weight" rating for the company in a research note on Thursday, April 24th. William Blair reissued an "outperform" rating on shares of Doximity in a report on Friday, May 16th. The Goldman Sachs Group set a $50.00 target price on Doximity and gave the stock a "neutral" rating in a report on Wednesday, May 21st. Finally, Evercore ISI raised Doximity from an "in-line" rating to an "outperform" rating and lifted their target price for the stock from $50.00 to $70.00 in a report on Wednesday, July 9th. Ten research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, Doximity currently has an average rating of "Moderate Buy" and a consensus target price of $64.89.

Check Out Our Latest Analysis on DOCS

Doximity Company Profile

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

See Also

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Should You Invest $1,000 in Doximity Right Now?

Before you consider Doximity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.

While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines